Stock NTC NETCARE LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Netcare Limited

Equities

NTC

ZAE000011953

Healthcare Facilities & Services

End-of-day quote Johannesburg S.E.
Other stock markets
 06:00:00 2024-05-19 pm EDT 		5-day change 1st Jan Change
11.75 ZAR +1.03% Intraday chart for Netcare Limited +0.51% -17.49%
May. 20 Transcript : Netcare Limited, H1 2024 Earnings Call, May 20, 2024
Mar. 25 NETCARE LTD: ERICH BOCK, HAS BEEN APPOINTED AS ACTING MANAGING D… RE

Valuation

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 23,597 17,357 21,636 18,344 17,968 15,340 - -
Enterprise Value (EV) 1 28,711 27,825 31,059 27,703 27,988 24,338 24,324 24,146
P/E ratio 10 x 46 x 29.8 x 19.1 x 14.4 x 10 x 8.37 x 7.29 x
Yield 6.32% - 2.1% 3.64% 4.81% 6.34% 7.79% 8.93%
Capitalization / Revenue 1.09 x 0.92 x 1.02 x 0.85 x 0.76 x 0.6 x 0.56 x 0.53 x
EV / Revenue 1.33 x 1.48 x 1.47 x 1.28 x 1.18 x 0.95 x 0.9 x 0.84 x
EV / EBITDA 6.54 x 10.9 x 9.57 x 7.95 x 7.01 x 5.28 x 4.81 x 4.42 x
EV / FCF -184 x -14.2 x 26.5 x 56.8 x 75 x 29 x 15.8 x 13.5 x
FCF Yield -0.54% -7.02% 3.78% 1.76% 1.33% 3.44% 6.35% 7.42%
Price to Book 2.47 x 1.89 x 2.18 x 1.79 x 1.6 x 1.23 x 1.21 x 1.19 x
Nbr of stocks (in thousands) 1,344,574 1,343,441 1,335,547 1,337,000 1,331,000 1,305,562 - -
Reference price 2 17.55 12.92 16.20 13.72 13.50 11.75 11.75 11.75
Announcement Date 11/18/19 11/23/20 11/22/21 11/21/22 11/21/23 - - -
1ZAR in Million2ZAR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 21,589 18,843 21,200 21,636 23,699 25,519 27,174 28,711
EBITDA 1 4,388 2,558 3,244 3,485 3,990 4,608 5,055 5,466
EBIT 1 3,640 1,393 2,076 2,282 2,716 3,247 3,647 4,008
Operating Margin 16.86% 7.39% 9.79% 10.55% 11.46% 12.73% 13.42% 13.96%
Earnings before Tax (EBT) 1 3,357 730 1,176 1,534 1,807 2,306 2,798 3,241
Net income 1 2,447 446 769 1,013 1,321 1,598 1,945 2,269
Net margin 11.33% 2.37% 3.63% 4.68% 5.57% 6.26% 7.16% 7.9%
EPS 2 1.750 0.2810 0.5430 0.7170 0.9350 1.171 1.404 1.612
Free Cash Flow 1 -156 -1,953 1,173 488 373 837.9 1,544 1,791
FCF margin -0.72% -10.36% 5.53% 2.26% 1.57% 3.28% 5.68% 6.24%
FCF Conversion (EBITDA) - - 36.16% 14% 9.35% 18.18% 30.55% 32.77%
FCF Conversion (Net income) - - 152.54% 48.17% 28.24% 52.43% 79.39% 78.94%
Dividend per Share 2 1.110 - 0.3400 0.5000 0.6500 0.7449 0.9157 1.049
Announcement Date 11/18/19 11/23/20 11/22/21 11/21/22 11/21/23 - - -
1ZAR in Million2ZAR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: September 2019 S2 2020 S1 2020 S2 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2
Net sales 1 11,069 10,713 8,130 10,081 11,119 10,311 11,325 11,537 12,162 12,295 13,081
EBITDA 1 - 2,360 - - 1,751 - 1,860 2,015 - 1,966 -
EBIT 1 - 1,787 - - 1,161 - - - - 1,325 -
Operating Margin - 16.68% - - 10.44% - - - - 10.78% -
Earnings before Tax (EBT) 1 - - - - - - - - - 863 -
Net income 1 - 583 - - - - - - - 585 -
Net margin - 5.44% - - - - - - - 4.76% -
EPS - - - - - - 0.3980 - - - -
Dividend per Share - - - - - - 0.3000 - - - -
Announcement Date 11/18/19 5/25/20 11/23/20 5/24/21 11/22/21 5/23/22 11/21/22 5/22/23 11/21/23 - -
1ZAR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 5,114 10,468 9,423 9,359 10,020 8,997 8,983 8,806
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.165 x 4.092 x 2.905 x 2.686 x 2.511 x 1.952 x 1.777 x 1.611 x
Free Cash Flow 1 -156 -1,953 1,173 488 373 838 1,544 1,791
ROE (net income / shareholders' equity) 24.4% 3.35% 8.07% 11% 12.1% 13.8% 15.6% 16.8%
ROA (Net income/ Total Assets) 11.1% 1.32% - 3.9% 4.89% 5.95% 7.3% 8.3%
Assets 1 21,960 33,737 - 25,946 27,036 26,859 26,648 27,335
Book Value Per Share 2 7.090 6.830 7.430 7.660 8.440 9.550 9.680 9.840
Cash Flow per Share 2 0.9000 -0.7400 1.720 1.400 1.400 1.200 2.020 2.270
Capex 1 1,378 961 1,132 1,396 1,507 1,258 1,389 1,523
Capex / Sales 6.38% 5.1% 5.34% 6.45% 6.36% 4.93% 5.11% 5.3%
Announcement Date 11/18/19 11/23/20 11/22/21 11/21/22 11/21/23 - - -
1ZAR in Million2ZAR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Netcare Limited

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
11.75 ZAR
Average target price
16 ZAR
Spread / Average Target
+36.21%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
NETCARE LIMITED Stock Netcare Limited
-17.49% 843M
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+18.58% 85.14B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-27.30% 72.06B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+2.75% 27.07B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-9.65% 17.43B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-1.96% 16.98B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+3.57% 16.02B
REDE D'OR SÃO LUIZ S.A. Stock Rede D'Or São Luiz S.A.
+8.76% 13.87B
NATERA, INC. Stock Natera, Inc.
+72.40% 13.06B
TENET HEALTHCARE CORPORATION Stock Tenet Healthcare Corporation
+73.18% 12.79B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. NTC Stock
  4. Financials Netcare Limited
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW